Clinical trial
Prophylactic Intervention for Dysgeusia in Head and Neck Cancer Patients Following Radio(Chemo)Therapy: a Randomized Control Trial
NCT07431346 is registered in ClinicalTrials.gov with Jules Bordet Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prophylactic Intervention for Dysgeusia in Head and Neck Cancer Patients Following Radio(Chemo)Therapy: a Randomized Control Trial
- Lead sponsor
- Jules Bordet Institute
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- February 1, 2026
- Completion date
- September 30, 2027
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
head and neck cancer (h&n)